Latest Tuberculosis treatment Stories
Immunitor, Inc., a commercial stage company committed to developing oral therapeutic vaccines, today announced that its second Phase II trial of oral TB vaccine with heat-killed Mycobacterium
Lauds Reduction in New Infections and Lowered Mortality Rate of TB; Urges More Aggressive Identification of Nearly 3 Million “Missed” New Cases of TB Annually and Greater Focus on More Virulent
Immunitor company announces publication of a successful clinical trial in 43 patients with tuberculosis who were given daily pill of therapeutic vaccine containing heat-killed Mycobacterium vaccae.
Virtual observation of patients taking their prescribed TB medication, could prove an effective technique for ensuring patients effectively complete their course of treatment.
Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis (TB) patients in a quarter of the time taken by the current method.
For years, physicians around the world have watched as strain after strain of the deadly bacteria Mycobacterium tuberculosis evolves resistance to drugs.
A new study has calculated the average cost per case of TB in the EU.
As part of the largest international research effort ever made to combat tuberculosis, a team of Johns Hopkins and Brazilian experts has found that preventive antibiotic therapy for people with HIV lowers this group's chances of developing TB or dying.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.